CAMBRIDGE, Mass.--(BUSINESS WIRE)--OvaScienceSM (NASDAQ: OVAS), a global fertility company focused on the discovery, development and commercialization of new treatment options, today reported second quarter 2015 financial results and highlighted recent accomplishments, including additional healthy births with the AUGMENTSM treatment at all clinics currently offering the treatment. In addition, the AUGMENT treatment will be available in Spain through the largest in vitro fertilization (IVF) clinic network in the world, as well as through another new clinic partnership in Latin America. The Company is also on track to meet the 2015 goals for the OvaPrimeSM and OvaTureSM treatments. The AUGMENT treatment is not available in the United States.
Help employers find you! Check out all the jobs and post your resume.
